Rolipram was previously shown to potently reduce weight gain in a diet-induced obesity mice model [22] and to prevent Alzheimer's disease [7], but the potential of a specific PDE4 inhibitor to serve as an anti-aging drug by improving metabolic functions has not yet been investigated. This evidence concerns the gene PDE4A and Alzheimer disease.